Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey

BJOG. 2024 Nov;131(12):1684-1693. doi: 10.1111/1471-0528.17891. Epub 2024 Jul 2.

Abstract

Objective: To identify current practices in the management of selective fetal growth restriction (sFGR) in monochorionic diamniotic (MCDA) twin pregnancies.

Design: Cross-sectional survey.

Setting: International.

Population: Clinicians involved in the management of MCDA twin pregnancies with sFGR.

Methods: A structured, self-administered survey.

Main outcome measures: Clinical practices and attitudes to diagnostic criteria and management strategies.

Results: Overall, 62.8% (113/180) of clinicians completed the survey; of which, 66.4% (75/113) of the respondents reported that they would use an estimated fetal weight (EFW) of <10th centile for the smaller twin and an inter-twin EFW discordance of >25% for the diagnosis of sFGR. For early-onset type I sFGR, 79.8% (75/94) of respondents expressed that expectant management would be their routine practice. On the other hand, for early-onset type II and type III sFGR, 19.3% (17/88) and 35.7% (30/84) of respondents would manage these pregnancies expectantly, whereas 71.6% (63/88) and 57.1% (48/84) would refer these pregnancies to a fetal intervention centre or would offer fetal intervention for type II and type III cases, respectively. Moreover, 39.0% (16/41) of the respondents would consider fetoscopic laser surgery (FLS) for early-onset type I sFGR, whereas 41.5% (17/41) would offer either FLS or selective feticide, and 12.2% (5/41) would exclusively offer selective feticide. For early-onset type II and type III sFGR cases, 25.9% (21/81) and 31.4% (22/70) would exclusively offer FLS, respectively, whereas 33.3% (27/81) and 32.9% (23/70) would exclusively offer selective feticide.

Conclusions: There is significant variation in clinician practices and attitudes towards the management of early-onset sFGR in MCDA twin pregnancies, especially for type II and type III cases, highlighting the need for high-level evidence to guide management.

Keywords: clinical trial; cord occlusion; definition; diagnosis; fetal growth restriction; feticide; fetoscopic laser surgery; intervention; intrauterine demise; morbidity; mortality; multiple; neonatal; pregnancy; prognosis; small for gestational age; stillbirth; surgery; survey.

MeSH terms

  • Attitude of Health Personnel
  • Cross-Sectional Studies
  • Female
  • Fetal Growth Retardation* / diagnosis
  • Fetal Growth Retardation* / therapy
  • Fetal Weight
  • Fetoscopy / methods
  • Humans
  • Laser Therapy / methods
  • Practice Patterns, Physicians'* / statistics & numerical data
  • Pregnancy
  • Pregnancy, Twin*
  • Surveys and Questionnaires
  • Twins, Monozygotic*
  • Ultrasonography, Prenatal

Grants and funding